CoreAge Rx vs MedLeanRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MedLeanRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make MedLeanRx a bad call — it's best for texas patients comparing a starting-dose plan with a branded prescription route who want an itemized quote before paying. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | MedLeanRx |
|---|---|---|
| Brief Score | 94/100 (A) | 71/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $149/mo starting-dose offer Compounded semaglutide vial; confirm the full prescribed dose and charge. Texas only. Full price detailsCompounded semaglutide offered; complete dose-specific quote unknown; $149/month starting-dose vial advertised; earlier listing: From $149/mo (starting dose, promotional rate, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $269/mo starting-dose offer Injection plan; confirm formulation and full dose-specific charge. Texas only. Brand-care fee of $99 excludes medication. Full price detailsCurrent tirzepatide formulation and complete quote unknown; injection plan advertised $269/month at starting dose; earlier listing: From $269/mo (starting dose, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Texas only according to current practice and product pages |
| Brand-name access | Not confirmed | Named branded options have a $99/month professional-service charge plus medication; that is not an all-inclusive drug price. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
MedLeanRx: Semaglutide vial $149 and tirzepatide injection $269 are starting-dose offers. Branded routes advertise $99 for professional services plus medication, not a $99 drug plan.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.